Jonathan S. Zager, MD

Cutaneous Surgeon
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States

Jonathan S. Zager, MD, FACS, FSSO
Chief Academic Officer
Moffitt Cancer Center
Director of Regional Therapies
Senior Member
Department of Cutaneous Oncology
Professor of Surgery and Chair, Department of Oncologic Sciences
University of South Florida Morsani College of Medicine

Dr Zager is an internationally recognized expert in melanoma and non-melanoma skin cancers and their diagnosis and management especially researching novel treatments for recurrent and in transit melanoma such percutaneous hepatic perfsuion for metastatic uveal melanoma to the liver and isolated limb infusion for unresectable intransit melanoma of the extrameity or limb threatneing sarcomas, intralesional injections. Dr Zager has published extensively on melanoma and non-melanoma skin cancers with over 300 peer reviewed publications, numerous textbook chapters and edited textbooks and over 500 national, international presetations and invited talks.

Presentation(s):

• P17: Management of Anorectal Melanoma in the Era of Modern Systemic Therapies

  Sunday, February 18, 2024
  2:45 PM - 2:50 PM AST

• Percutaneous Hepatic Perfusion for Hepatic Dominant Metastatic Uveal Melanoma

  Sunday, February 18, 2024
  3:45 PM - 4:05 PM AST

• Setting Up a Percutaneous Hepatic Perfusion Program: A Panel Discussion

  Sunday, February 18, 2024
  4:05 PM - 4:30 PM AST

• 32: Isolated Limb Infusion as First, Second, or Third-Line Therapy for Melanoma with In-Transit Metastasis

  Monday, February 19, 2024
  8:10 AM - 8:20 AM AST

• 35: Hepatic and Overall Progression-Free Survival after Percutaneous Hepatic Perfusion as First-Line or Second-Line Therapy for Metastatic Uveal Melanoma

  Monday, February 19, 2024
  8:40 AM - 8:50 AM AST

• 43: Isolated Limb Infusion for Limb Threatening Sarcomas

  Monday, February 19, 2024
  9:30 AM - 9:40 AM AST